Luciferase Actviity

Lab Reagents

Human IgG antibody Laboratories manufactures the luciferase actviity reagents distributed by Genprice. The Luciferase Actviity reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Actviity

Chemicals information

AAV6 Luciferase
78457 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 6 (AAV6) appears to be related to AAV1 by sequence analysis and shows the best transduction efficiency in pancreatic beta-cells compared to other AAV serotypes. AAV6 vectors are also particularly effective in the transduction of human prostate, breast, and liver cancer cells._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV8 Luciferase
78458 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 8 (AAV8) was isolated from rhesus monkey tissue, and the AAV8 rep and cap nucleotide sequences have 88% homology with AAV7 and 82% with AAV2. AAV8 exhibits greater transduction efficiency in the liver than other AAV serotypes. AAV8 and 9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV9 Luciferase
78459 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications.         _x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

Luciferase antibody (biotin)
60C-CR2029GAB 500 ul
EUR 516
Description: Goat polyclonal Luciferase antibody (biotin) conjugated

Luciferase antibody (FITC)
60C-CR2029GAF 500 ul
EUR 327.6
Description: Affinity purified Goat polyclonal Luciferase antibody (FITC)

Luciferase antibody (biotin)
60C-CR2029GT 10 mg
EUR 4510.8
Description: Rabbit polyclonal Luciferase antibody (Biotin)

Luciferase antibody (FITC)
60C-CR2029RAF 500 ul
EUR 516
Description: Affinity purified Rabbit polyclonal Luciferase antibody (FITC)

Luciferase Polyclonal Antibody
30382-100ul 100ul
EUR 302.4

Luciferase Polyclonal Antibody
30382-50ul 50ul
EUR 224.4

Firefly Luciferase Antibody
48664-100ul 100ul
EUR 399.6

Firefly Luciferase Antibody
48664-50ul 50ul
EUR 286.8

Renilla Luciferase Antibody
48665-100ul 100ul
EUR 399.6

Renilla Luciferase Antibody
48665-50ul 50ul
EUR 286.8

Renilla Luciferase Antibody
45035-100ul 100ul
EUR 302.4

Renilla Luciferase Antibody
45035-50ul 50ul
EUR 224.4

Luciferase *Recombinant firefly*
12500 1 mL
EUR 158.4

Renilla mullerei Luciferase,
0309-1 1 mg Ask for price